Ashish Kacholia's Portfolio Company's Azadirachtin-Based Product Secures Government Approval for Revolutionary Public Health (Mosquito Control) Application Ashish Kacholia's Portfolio Company's Azadirachtin-Based Product Secures Government Approval for Revolutionary Public Health (Mosquito Control) Application The company has a market cap of Rs 3,000 crore with an ROE of 30 per cent and an ROCE of 39 per cent. Kiran Shroff / Monday, February 17, 2025 / Article rating: 4.6 The stock gave multibagger returns of over 880 per cent returns in 5 years.